HLF and Parkinson disease: Growing evidence in favor of HIF-1α being the key factor in the mechanism of neuroprotection used by chelators, including Lf [13], [53], we subsequently assessed the expression and activation of HIF-1α protein and its signal system in the PD mouse brains in both hLf- and vehicle-treated mice.